Deal or Case news
06.12.2024
Anima Research, a leading clinical trial centre, secured investment from BNP Paribas Fortis Private Equity, who becomes a minority stakeholder.

Anima Research intends to use the funding to support the expansion of Anima Research’ clinical trial operations in Europa. Alongside BNP Paribas Fortis Private Equity, two key managers of Anima Research made an investment.

It has been a great pleasure to support Anima Research in reaching this important milestone, which will enable them to accelerate their expansion plans.
Dirk Van Gerven, Managing Partner Brussels

Transaction team
Our team consisted of Corporate/M&A Dirk Van Gerven, Louisa Vandepitte, Don Baudewyns and Life Science experts Vincent Wellens and Florence Verhoestraete.

About Anima Research
Founded in 2018 and based in Alken (Belgium), Anima Research is one of Europe’s leading clinical trial centers. It partners with top-tier pharmaceutical companies and manages trials for a range of therapy areas including women’s health diseases, sleep disorders, heart disease, lung disease, skin conditions and mental disorders.

Media coverage
De Tijd
GlobeNewswire

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.